James Moriarty

Mr. Moriarty is an entrepreneur with more than four decades of experience in the pharmaceutical industry. He currently is the Chief Executive Officer and owner of The Synapse Group, Inc., a specialty consulting practice with operations in the United States and Canada. Synapse has helped pioneer programs and processes that address the unique information requirements of medical specialists working in technically-sophisticated fields including organ transplantation, cancer, infectious disease, rheumatology, immunology, cardiovascular disease, and vaccines.

Mr. Moriarty spent the first 13 years of his career working for two large multi-national pharmaceutical manufacturers, where he progressed through positions of increasing responsibility in marketing management, new business development, product acquisition and licensing clinical operations, and regulatory affairs. He is a member of the board of directors of BlueRush Media Group Corp. located in Toronto, Canada, and Lisoma Canada, a subsidiary of Lisoma International Ltd, a pharmaceutical manufacturer located in the United Kingdom.

Mr. Moriarty received his bachelor of science degree from St. Francis Xavier University.